Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARGX Argenx SE

未开盘 05-09 16:00:00 EDT

382.55

-3.53

-0.91%

盘后383.50

+0.95+0.25%

16:51 EDT

最高385.57	最低361.00	成交量60.72万
今开380.44	昨收386.08	日振幅6.36%
总市值227.18亿	流通市值225.29亿	总股本5,939万
成交额2.29亿	换手率1.03%	流通股本5,889万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARGX","market":"US","secType":"STK","nameCN":"Argenx SE","latestPrice":382.55,"timestamp":1715284800000,"preClose":386.08,"halted":0,"volume":607234,"hourTrading":{"tag":"盘后","latestPrice":383.5,"preClose":382.55,"latestTime":"16:51 EDT","volume":6406,"amount":2451005.89,"timestamp":1715287911608},"delay":0,"floatShares":58890777,"shares":59386542,"eps":-5.161043,"marketStatus":"未开盘","marketStatusCode":0,"change":-3.53,"latestTime":"05-09 16:00:00 EDT","open":380.44,"high":385.57,"low":361,"amount":229361833.59082,"amplitude":0.06364,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.161043,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715328000000},"adr":1,"listingDate":1495080000000,"adjPreClose":386.08,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":377.82,"preClose":386.08,"latestTime":"09:29 EDT","volume":7763,"amount":2798446.6076,"timestamp":1715261392014},"postHourTrading":{"tag":"盘后","latestPrice":383.5,"preClose":382.55,"latestTime":"16:51 EDT","volume":6406,"amount":2451005.89,"timestamp":1715287911608},"volumeRatio":2.92943},"requestUrl":"/m/hq/s/ARGX/wiki","defaultTab":"wiki","newsList":[{"id":"1191142657","title":"盘前｜美股三大股指期货齐跌！“元宇宙第一股” 绩后暴跌逾30%，一中概股绩后飙涨20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191142657","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1191142657?lang=zh_cn&edition=full","pubTime":"2024-05-09 20:20","pubTimestamp":1715257234,"startTime":"0","endTime":"0","summary":"5月9日，美股三大股指期货小幅走低，截止发稿，道指期货跌0.15%，纳指期货跌0.15%，标普500指数期货跌0.11%。热点资讯英国央行维持基准利率在5.25%不变，符合市场预期；“元宇宙第一股”Roblox第二季度预订展望未达预期；市场消息：Alphabet据悉在潜在的Hubspot交易谈判中取得了进展；市场消息：辉瑞同意就1万多起Zantac癌症诉讼达成和解；再鼎医药Q1产品收入净额8710万美元，同比增长39%；Arm第四财季营收高于预期，但2025财年营收展望较为疲软；收入下降18%！","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":1},{"id":"2434604063","title":"荷兰生物技术公司Argenx盘前跌近7%，Q1营收低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2434604063","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2434604063?lang=zh_cn&edition=full","pubTime":"2024-05-09 16:39","pubTimestamp":1715243990,"startTime":"0","endTime":"0","summary":"","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433172958","title":"Argenx Se涨0.32% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2433172958","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433172958?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:31","pubTimestamp":1715175108,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时31分，Argenx Se股票出现波动，股价大幅拉升0.32%。截至发稿，该股报400.09美元/股，成交量1759股，换手率0.00%，振幅0.06%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.25%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508213148861ebc4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508213148861ebc4c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422616181","title":"Argenx Se涨0.45% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2422616181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422616181?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:31","pubTimestamp":1711459919,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时31分，Argenx Se股票出现异动，股价急速拉升0.45%。截至发稿，该股报400.22美元/股，成交量4542股，换手率0.01%，振幅0.34%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.41%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326213159861e13dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326213159861e13dc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422251702","title":"Argenx Se跌1.63% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2422251702","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422251702?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:31","pubTimestamp":1711373507,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时31分，Argenx Se股票出现异动，股价急速跳水1.63%。截至发稿，该股报396.12美元/股，成交量5393股，换手率0.01%，振幅0.13%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.52%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252131478b6139c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252131478b6139c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421063848","title":"Argenx Se涨0.83% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2421063848","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421063848?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:06","pubTimestamp":1711119960,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时06分，Argenx Se股票出现异动，股价大幅拉升0.83%。截至发稿，该股报400.16美元/股，成交量7.545万股，换手率0.13%，振幅2.71%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.18%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223060187e7b17a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223060187e7b17a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417126703","title":"Argenx Se2023财年实现净利润-2.96亿美元，同比增加58.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417126703","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417126703?lang=zh_cn&edition=full","pubTime":"2024-03-05 00:26","pubTimestamp":1709569603,"startTime":"0","endTime":"0","summary":"12月31日，Argenx Se公布财报，公告显示公司2023财年净利润为-2.96亿美元，同比增加58.31%；其中营业收入为12.28亿美元，同比增加198.78%，每股基本收益为-5.17美元。从资产负债表来看，Argenx Se总负债4.45亿美元，其中短期债务4.65百万美元，资产负债比为10.21，流动比率为9.75。机构评级：截至2023年12月31日，当前有30家机构对Argenx Se目标价做出预测，其中目标均价为467.65美元，其中最低目标价为178.55美元，最高目标价为573.20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305002654874ddc21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305002654874ddc21&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415790343","title":"Argenx Se跌2.76% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2415790343","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415790343?lang=zh_cn&edition=full","pubTime":"2024-02-28 23:42","pubTimestamp":1709134962,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日23时42分，Argenx Se股票出现波动，股价快速下跌2.76%。截至发稿，该股报399.86美元/股，成交量7.2368万股，换手率0.12%，振幅1.93%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.34%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402282342427a47c73e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402282342427a47c73e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412034581","title":"Argenx Se涨3.27% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2412034581","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412034581?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:32","pubTimestamp":1708439565,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日22时32分，Argenx Se股票出现波动，股价急速拉升3.27%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.36%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。Vyvgart 于2021年12月在美国被批准用于治疗广泛性重症肌无力，随后于2022年在欧洲和日本获得批准。消息层面，截至22时32分，《美国FDA受理Argenx艾加莫德皮下注射用于治疗CIDP的补充上市申请并纳入优先审评》资讯为影响Argenx Se的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022324587a57d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022324587a57d66&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412147168","title":"美国FDA受理Argenx(ARGX.US)艾加莫德皮下注射用于治疗CIDP的补充上市申请并纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2412147168","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2412147168?lang=zh_cn&edition=full","pubTime":"2024-02-20 16:13","pubTimestamp":1708416804,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荷兰生物技术公司Argenx宣布，美国食品药品监督管理局已经受理了艾加莫德皮下注射用于治疗慢性炎性脱髓鞘性多发性神经根神经病的补充生物制剂上市许可申请并将其纳入优先审评。ADHERE研究旨在评估艾加莫德皮下注射用于治疗CIDP成人患者的安全性和有效性。该研究达到了主要终点，与安慰剂相比，艾加莫德皮下注射可降低复发风险61%。在开放标签A阶段，67%的患者接受艾加莫德皮下注射治疗后显示出临床改善的证据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1073758.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2410284077","title":"Argenx Se跌1.92% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2410284077","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410284077?lang=zh_cn&edition=full","pubTime":"2024-02-12 22:31","pubTimestamp":1707748315,"startTime":"0","endTime":"0","summary":"北京时间2024年02月12日22时31分，Argenx Se股票出现异动，股价大幅跳水1.92%。截至发稿，该股报393.76美元/股，成交量1.182万股，换手率0.02%，振幅0.74%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.42%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402122231558185fee4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402122231558185fee4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410054620","title":"Argenx Se涨1.29% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2410054620","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410054620?lang=zh_cn&edition=full","pubTime":"2024-02-09 23:05","pubTimestamp":1707491151,"startTime":"0","endTime":"0","summary":"北京时间2024年02月09日23时05分，Argenx Se股票出现异动，股价大幅拉升1.29%。截至发稿，该股报400.00美元/股，成交量1.725万股，换手率0.03%，振幅0.81%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.70%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。Vyvgart 于2021年12月在美国被批准用于治疗广泛性重症肌无力，随后于2022年在欧洲和日本获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209230551861d4dac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209230551861d4dac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409940434","title":"Argenx Se跌2.37% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2409940434","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409940434?lang=zh_cn&edition=full","pubTime":"2024-02-06 22:32","pubTimestamp":1707229937,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日22时32分，Argenx Se股票出现波动，股价快速跳水2.37%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Exicure Inc涨幅较大，Tenax Therapeutics Inc、Invivo Therapeutics Holding Corp、Exicure Inc较为活跃，换手率分别为941.95%、549.09%、41.21%，振幅较大的相关个股有Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Sagimet Biosciences Inc，振幅分别为85.68%、35.21%、13.60%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402062232178774bd80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402062232178774bd80&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409432067","title":"Argenx Se盘中异动 临近午盘股价大涨5.00%报397.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409432067","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409432067?lang=zh_cn&edition=full","pubTime":"2024-02-06 00:30","pubTimestamp":1707150627,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日00时30分，Argenx Se股票出现波动，股价急速拉升5.00%。截至发稿，该股报397.78美元/股，成交量18.4224万股，换手率0.31%，振幅5.05%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.32%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060030277a418410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060030277a418410&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2404056086","title":"隔夜美股全复盘(1.19)| 三大股指高开高收，台积电大涨10%，Q4业绩和下季指引全线超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2404056086","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2404056086?lang=zh_cn&edition=full","pubTime":"2024-01-19 07:25","pubTimestamp":1705620309,"startTime":"0","endTime":"0","summary":"三大股指高开高收，台积电大涨10%，Q4业绩和下季指引全线超预期","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/686019","is_publish_highlight":false,"gpt_icon":0},{"id":"2404237510","title":"日本批准Argenx(ARGX.US)VYVDURA皮下注射剂用于治疗全身型重症肌无力","url":"https://stock-news.laohu8.com/highlight/detail?id=2404237510","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2404237510?lang=zh_cn&edition=full","pubTime":"2024-01-18 15:28","pubTimestamp":1705562906,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荷兰生物技术公司Argenx(ARGX.US)宣布，日本厚生劳动省批准VYVDURA皮下注射剂用于治疗成人全身型重症肌无力(gMG)。VYVGART现已在日本被批准用于静脉注射和皮下注射。该公司指出，此次批准是基于3期ADAPT-SC研究的积极结果。Argenx日本总经理Hermann Strenger表示：“将VYVDURA引入日本意味着现在有两种药剂可供gMG患者使用，包括在家自行注射，允许患者和他们的医疗保健提供者选择最佳方案来满足治疗需求。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1057316.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2402159357","title":"Argenx Se跌3.22% 股价跌破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2402159357","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402159357?lang=zh_cn&edition=full","pubTime":"2024-01-10 01:28","pubTimestamp":1704821292,"startTime":"0","endTime":"0","summary":"北京时间2024年01月10日01时28分，Argenx Se股票出现波动，股价急速跳水3.22%。截至发稿，该股报399.99美元/股，成交量13.9122万股，换手率0.24%，振幅3.09%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.54%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240110012812861c978f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240110012812861c978f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2401957820","title":"Argenx Se涨1.43% 股价突破400美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2401957820","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401957820?lang=zh_cn&edition=full","pubTime":"2024-01-08 22:33","pubTimestamp":1704724381,"startTime":"0","endTime":"0","summary":"北京时间2024年01月08日22时33分，Argenx Se股票出现波动，股价大幅上涨1.43%。截至发稿，该股报401.88美元/股，成交量1.0704万股，换手率0.02%，振幅0.81%。Argenx Se股票所在的生物技术行业中，整体跌幅为1.06%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。Vyvgart 于2021年12月在美国被批准用于治疗广泛性重症肌无力，随后于2022年在欧洲和日本获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240108223301861c925a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240108223301861c925a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393348714","title":"Argenx Se盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2393348714","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393348714?lang=zh_cn&edition=full","pubTime":"2023-12-22 04:50","pubTimestamp":1703191823,"startTime":"0","endTime":"0","summary":"北京时间2023年12月22日04时50分，Argenx Se股票出现波动，股价急速拉升5.25%。截至发稿，该股报356.70美元/股，成交量199.552万股，换手率3.38%，振幅8.55%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.80%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。消息层面，截至04时50分，Argenx Se股票正面舆情新闻比例15.38%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312220450247902c0d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312220450247902c0d8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392569192","title":"Argenx Se股价重挫24.59% 市值跌49.58亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392569192","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392569192?lang=zh_cn&edition=full","pubTime":"2023-12-20 22:31","pubTimestamp":1703082666,"startTime":"0","endTime":"0","summary":"北京时间2023年12月20日22时31分，Argenx Se股票出现异动，股价急速下挫24.59%。截至发稿，该股报341.30美元/股，成交量97.726万股，换手率1.65%，振幅1.39%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.92%。Argenx Se公司简介：argenx SE是一家荷兰公司，专注于利用其抗体工程技术治疗罕见的自身免疫性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231220223106875c68d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231220223106875c68d8&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.argenx.com","stockEarnings":[{"period":"1week","weight":-0.0276},{"period":"1month","weight":-0.0041},{"period":"3month","weight":-0.0472},{"period":"6month","weight":-0.2179},{"period":"1year","weight":-0.0493},{"period":"ytd","weight":0.0056}],"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0378},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0944}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Argenx Se根据荷兰法律于2008年4月25日成立，是一家私人有限责任公司（besloten vennootschap met beperkte aansprakelijkheid）。 于2014年5月28日，根据公证转换契约及修订，该公司转为上市有限责任公司（naamloze vennootschap）。 该公司是一家处于商业阶段的、全球性的、完全整合的生物制药公司，开发用于治疗严重自身免疫性疾病的差异化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.000942},{"month":2,"riseRate":0.428571,"avgChangeRate":0.053858},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.014172},{"month":4,"riseRate":0.714286,"avgChangeRate":0.0249},{"month":5,"riseRate":0.714286,"avgChangeRate":0.088965},{"month":6,"riseRate":0.857143,"avgChangeRate":0.051985},{"month":7,"riseRate":0.571429,"avgChangeRate":0.05209},{"month":8,"riseRate":0.571429,"avgChangeRate":0.013188},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.040401},{"month":10,"riseRate":0.571429,"avgChangeRate":0.020323},{"month":11,"riseRate":0.714286,"avgChangeRate":0.125937},{"month":12,"riseRate":0.571429,"avgChangeRate":0.160659}],"exchange":"NASDAQ","name":"Argenx SE","nameEN":"Argenx SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Argenx SE,ARGX,Argenx SE股票,Argenx SE股票老虎,Argenx SE股票老虎国际,Argenx SE行情,Argenx SE股票行情,Argenx SE股价,Argenx SE股市,Argenx SE股票价格,Argenx SE股票交易,Argenx SE股票购买,Argenx SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}